Comparing Heavy Levobupivacaine With Enantiomeric Excess of 50% and Heavy Racemic Bupivacaine.

NCT01308047 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The Sponsor has no interest in continuing the study.

Conditions

Fracture of Lower Limb

Interventions

DRUG: Bupivacaine

Sponsor

Cristália Produtos Químicos Farmacêuticos Ltda.

Collaborators

[object Object]
[object Object]